Showing results 9 to 11 of 11
< previous
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
2016 | 54 | |||
2019 | 44 | |||
The PAR-1 antagonist Vorapaxar ameliorates kidney injury and tubulointerstitial fibrosis Journal:Clinical Science | 2020 | 39 |
Title | Author(s) | Issue Date | Views | |
---|---|---|---|---|
2016 | 54 | |||
2019 | 44 | |||
The PAR-1 antagonist Vorapaxar ameliorates kidney injury and tubulointerstitial fibrosis Journal:Clinical Science | 2020 | 39 |